13F
中

NAGE NIAGEN BIOSCIENCE INC

2026Q1 · CUSIP 171077407 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
143
Δ holders QoQ
-25
Breadth percentile
Top 94%
Whale holders
81
Δ whales
-14
Inst. holding value
$166M
New positions
24
Closed positions
49
Price momentum (1Q)
-29.7%
Put / Call
3/4

Breadth history (34 quarters)

2018Q1: Δ+4 · h=58 2018Q2: Δ+7 · h=65 2018Q3: Δ+0 · h=65 2018Q4: Δ-3 · h=62 2019Q1: Δ-2 · h=60 2019Q2: Δ+0 · h=60 2019Q3: Δ+2 · h=62 2019Q4: Δ+6 · h=68 2020Q1: Δ-5 · h=63 2020Q2: Δ+5 · h=68 2020Q3: Δ+12 · h=80 2020Q4: Δ+5 · h=85 2021Q1: Δ+11 · h=96 2021Q2: Δ+7 · h=103 2021Q3: Δ-14 · h=89 2021Q4: Δ-4 · h=85 2022Q1: Δ-2 · h=83 2022Q2: Δ-7 · h=76 2022Q3: Δ-13 · h=63 2022Q4: Δ-4 · h=59 2023Q1: Δ+1 · h=60 2023Q2: Δ-4 · h=56 2023Q3: Δ-1 · h=55 2023Q4: Δ-1 · h=54 2024Q1: Δ+14 · h=68 2024Q2: Δ+11 · h=79 2024Q3: Δ+13 · h=92 2024Q4: Δ+32 · h=124 2025Q1: Δ+16 · h=140 2025Q2: Δ+16 · h=156 2025Q3: Δ+6 · h=162 2025Q4: Δ+6 · h=168 2026Q1: Δ-25 · h=143 2018Q1: holders=58 2018Q2: holders=65 2018Q3: holders=65 2018Q4: holders=62 2019Q1: holders=60 2019Q2: holders=60 2019Q3: holders=62 2019Q4: holders=68 2020Q1: holders=63 2020Q2: holders=68 2020Q3: holders=80 2020Q4: holders=85 2021Q1: holders=96 2021Q2: holders=103 2021Q3: holders=89 2021Q4: holders=85 2022Q1: holders=83 2022Q2: holders=76 2022Q3: holders=63 2022Q4: holders=59 2023Q1: holders=60 2023Q2: holders=56 2023Q3: holders=55 2023Q4: holders=54 2024Q1: holders=68 2024Q2: holders=79 2024Q3: holders=92 2024Q4: holders=124 2025Q1: holders=140 2025Q2: holders=156 2025Q3: holders=162 2025Q4: holders=168 2026Q1: holders=143 -32 -16 +0 +16 +32 48113177 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 19% -32.1% -50.6%
2025Q1 Top 15% -11.9% -36.6%
2024Q4 Top 16% +84.9% +62.9%

Options Sentiment

Put holders
3
QoQ: +1
Call holders
4
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
16.0
EPS (TTM)
$0.21
EPS YoY
+16.7%
Revenue (TTM)
$0.1B
Revenue YoY
+20.8%
Quarterly Revenue & EPS (4Y)
2022-06-30: $17M 2022-09-30: $17M 2022-12-31: $21M 2023-03-31: $23M 2023-06-30: $20M 2023-09-30: $19M 2023-12-31: $21M 2024-03-31: $22M 2024-06-30: $23M 2024-09-30: $26M 2024-12-31: $29M 2025-03-31: $30M 2025-06-30: $31M 2025-09-30: $34M 2025-12-31: $34M 2026-03-31: $31M 2022-06-30: EPS -0.09 2022-09-30: EPS -0.01 2022-12-31: EPS -0.03 2023-03-31: EPS -0.03 2023-06-30: EPS -0.03 2023-09-30: EPS -0.01 2023-12-31: EPS 0.00 2024-03-31: EPS -0.01 2024-06-30: EPS 0.00 2024-09-30: EPS 0.02 2024-12-31: EPS 0.10 2025-03-31: EPS 0.06 2025-06-30: EPS 0.04 2025-09-30: EPS 0.05 2025-12-31: EPS 0.05 2026-03-31: EPS 0.07 0M 17M 34M $M -0.10 0.01 0.11 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 46 2024-09-30: PE 6822024-12-31: PE 53.42025-03-31: PE 60.82025-06-30: PE 45.52025-09-30: PE 27.52025-12-31: PE 25.72026-03-31: PE 17.4 16 366 716 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)